行情

LGND

LGND

Ligand Pharma
NASDAQ

实时行情|Nasdaq Last Sale

108.47
-0.43
-0.39%
已收盘, 16:11 11/12 EST
开盘
108.80
昨收
108.90
最高
110.97
最低
107.57
成交量
33.14万
成交额
--
52周最高
166.52
52周最低
84.45
市值
20.62亿
市盈率(TTM)
3.901
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

LGND 新闻

  • 沪指低开震荡 纳指再创新高、期金连跌四日
  • 新浪财经.2小时前
  • 蔚来汽车聘请中金汽车行业分析师为下任首席财务官
  • 新浪财经综合.3小时前
  • 蔚来否认咨询破产清算:纯属造谣 已启动法律程序
  • 新浪科技.3小时前
  • 同样搞流媒体 迪斯尼服务器被挤爆苹果却“糊”了
  • 新浪财经综合.3小时前

更多

所属板块

生物技术和医学研究
+0.45%
制药与医学研究
+0.31%

热门股票

名称
价格
涨跌幅

LGND 简况

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others.
展开

Webull提供Ligand Pharmaceuticals Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。